Predictors of Adverse TB Treatment Outcome among TB/HIV Patients Compared with Non-HIV Patients in the Greater Accra Regional Hospital from 2008 to 2016
Table 2
Disease characteristics of TB cases according to HIV status in the Greater Accra Regional Hospital, 2008-2016.
Characteristics (758)
TB-HIV (%)
TB-only (%)
Total (%)
value
Category of patienta
0.149
New
139 (78.9)
429 (73.5)
568 (74.93)
Relapse
5 (2.9)
13 (2.2)
18 (2.37)
Defaulter
0
12 (2.1)
12 (1.6)
Failure
1 (0.6)
3 (0.5)
4 (0.5)
Undefined
28 (16.1)
125 (21.4)
153 (20.2)
Transferred in
1 (0.6)
2 (0.3)
3 (0.4)
TB classification
<0.001
Smear positive
74 (42.5)
337 (57.7)
411 (54.2)
Smear negative
65 (37.4)
109 (18.7)
174 (23.0)
Extrapulmonary
35 (20.1)
138 (23.6)
173 (22.8)
Chest X-ray
0.085
Suggestive
114 (65.5)
340 (58.2)
454 (59.9)
Not suggestive
60 (34.5)
244 (41.8)
304 (40.1)
Duration of treatment
0.750
<6 months
15 (8.6)
55 (9.4)
70 (9.2)
≥6 months
159 (91.4)
529 (90.6)
688 (90.8)
Diabetes
0.274
Yes
8 (4.6)
17 (2.9)
25 (3.3)
No
166 (95.4)
567 (97.1)
733 (96.7)
Adverse treatment reactiona
0.052
Yes
4 (2.3)
3 (0.5)
7 (0.9)
No
170 (97.7)
581 (99.5)
751 (99.1)
Significant at .aSignificance was determined using Fisher’s exact test.
